{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-025782","form_type":"8-K","ticker":"RMTI","cik":"0001041024","company_name":"ROCKWELL MEDICAL, INC.","filed_at":"2025-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.772882+00:00","generated_at":"2026-05-24T09:40:29.854905+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Rockwell Medical Reports Record Net Sales and First Full-Year Adjusted EBITDA Profitability in 2024","bullets":["Record net sales of $101.5M in 2024, a 21% increase over 2023.","Record gross profit of $17.5M in 2024, a 101% increase over 2023.","Full-year adjusted EBITDA reached $5.2M, first time profitable on that basis.","Net loss improved 94% to $0.5M in 2024 from $8.4M in 2023.","Largest customer transitioning away; expects ~$34M revenue loss in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-025782","json":"https://secwatch.observer/filing/0001104659-25-025782.json","markdown":"https://secwatch.observer/filing/0001104659-25-025782.md","text":"https://secwatch.observer/filing/0001104659-25-025782.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1041024/000110465925025782/0001104659-25-025782-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1041024/000110465925025782/tm259810d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-24T09:40:29.854905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}